Open AccessA dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients
Author(s) -
Shuichi Sato,
Tatsuya Miyake,
Hiroshi Tobita,
Naoki Oshima,
Junichi Ishine,
Takuya Hanaoka,
Yuji Amano,
Yoshikazu Kinoshita
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.2782
Subject(s) - ursodeoxycholic acid , medicine , gastroenterology , cirrhosis , elevated transaminases , alanine transaminase , hepatitis c , liver disease , adverse effect , aspartate transaminase , oral administration , alkaline phosphatase , chemistry , enzyme , biochemistry
To examine whether a dose-up to 900 mg of ursodeoxycholic acid (UDCA) decreases transaminases in hepatitis C patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom